AYV:EURONEXT PARISAyvens Analysis
Data as of 2026-06-28 - not real-time
SGD 0.16
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Acma Ltd. is trading at SGD 0.155, barely above the computed support of SGD 0.154 and well below its 20‑day SMA of SGD 0.193, indicating short‑term pressure. The RSI of 28.7 places the stock in oversold territory, while the MACD histogram remains negative, signaling bearish momentum despite an increasing volume trend. Market sentiment is extremely bullish (Fear & Greed Index 88.55), yet the stock’s volatility is soaring at over 93% on a 30‑day basis and its beta is negative (-0.595), suggesting heightened idiosyncratic risk.
Fundamentally, revenue has slipped 20% year‑over‑year and operating margins sit at –17%, resulting in negative EBITDA and a trailing EPS of –0.03. However, the company generates positive operating cash flow (SGD 371k) and free cash flow (SGD 685k), and its net cash position (cash SGD 1.613 M vs debt SGD 0.677 M) provides a cushion. The DCF‑derived fair value of SGD 0.198 exceeds the current price, implying upside, but a price‑to‑book of 11.9 and a ROE of –83% highlight valuation and profitability concerns.
Fundamentally, revenue has slipped 20% year‑over‑year and operating margins sit at –17%, resulting in negative EBITDA and a trailing EPS of –0.03. However, the company generates positive operating cash flow (SGD 371k) and free cash flow (SGD 685k), and its net cash position (cash SGD 1.613 M vs debt SGD 0.677 M) provides a cushion. The DCF‑derived fair value of SGD 0.198 exceeds the current price, implying upside, but a price‑to‑book of 11.9 and a ROE of –83% highlight valuation and profitability concerns.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price hovering just above technical support
- Oversold RSI suggesting potential rebound
- Bearish MACD and high short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- DCF fair value above market price
- Positive free cash flow and net cash position
- Low price‑to‑sales ratio near 1.0
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Sustained operating losses and negative ROE
- High debt‑to‑equity ratio for a small‑cap
- Consumer‑cyclical exposure to economic downturns
Key Metrics & Analysis
Financial Health
Revenue Growth-20.20%
Profit Margin-17.27%
ROE-82.96%
ROA-12.03%
Debt/Equity62.00
P/B Ratio11.9
Op. Cash FlowSGD371.0K
Free Cash FlowSGD684.8K
Technical Analysis
TrendNeutral
RSI28.7
SupportSGD 0.15
ResistanceSGD 0.23
MA 20SGD 0.19
MA 50SGD 0.23
MA 200SGD 0.15
MACDBearish
VolumeIncreasing
Fear & Greed Index88.55
Valuation
Fair ValueSGD 0.20
GradeUndervalued
TypeValue
Risk Assessment
Beta-0.59
Volatility93.49%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.